Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phage display and pharmacogenomics.

R C Ladner1

  • 1Dyax Corp, Cambridge, MA 02139, USA. bladner@dyax.com

Pharmacogenomics
|March 21, 2001
PubMed
Summary
This summary is machine-generated.

Surface display technology enables the creation of specific binding agents for various targets, particularly proteins. Phage display now offers a robust method for protein tracking in pharmacogenomic studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases.

Protein engineering, design & selection : PEDS·2005
Same author

Novel frameworks as a source of high-affinity ligands.

Current opinion in biotechnology·2001
Same author

Inflammation and infection imaging with a 99mTc-neutrophil elastase inhibitor in monkeys.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2000
Same author

Polypeptides from phage display. A superior source of in vivo imaging agents.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·1999
Same author

Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·1999
Same author

Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1998
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Pharmacogenomics

Background:

  • Surface display technology generates specific binding agents for diverse targets, excelling with protein targets.
  • Pharmacogenomic studies traditionally track cellular responses via mRNA, due to ease of nucleic acid ligand production.
  • Direct protein tracking is sometimes preferred over mRNA analysis in pharmacogenomic research.

Purpose of the Study:

  • To highlight the utility of surface display and phage display technologies in pharmacogenomic studies.
  • To present phage display as a method for generating specific protein binding agents.
  • To emphasize the advantages of direct protein tracking in pharmacogenomics.

Main Methods:

  • Utilizing surface display of genetic diversity to create binding agents.

Related Experiment Videos

  • Employing phage display of peptides and proteins, including antibodies.
  • Generating nucleic acid ligands from known gene sequences.

    • Main Results:

    • Surface display can produce specific binding agents for nearly any target molecule.
    • Phage display provides a high throughput of specific binding agents, suitable for protein tracking.
    • This technology facilitates direct protein tracking in pharmacogenomic applications.

    Conclusions:

    • Phage display is a powerful tool for generating specific protein binding agents.
    • The technology enables direct protein tracking, complementing mRNA-based methods in pharmacogenomics.
    • Surface display and phage display advance the capabilities of pharmacogenomic research.